Brigatinib is a targeted therapy drug whose main component is a tyrosine kinase inhibitor.
Authentic
Guarantee
Fast Delivery
Privacy Use in Special PopulationsKey patient populations requiring close monitoring and precautions are as follows:Pregnant WomenThere are currently no clini···【Read More】
Update: 02 Mar,2026Source: Haiou HealthViews: 71
What Diseases Can Brigatinib TreatWhen used as monotherapy, brigatinib is specifically indicated for ALK-positive mid-to-late stage or metastatic non-···【Read More】
Update: 02 Mar,2026Source: Haiou HealthViews: 71
Copyright2024@ BIGBEAR All right reserved BIGBEAR



